These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9298430)

  • 21. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
    Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
    J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J; Aubin V
    Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression.
    Tignol J
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):18S-22S. PubMed ID: 8106650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.
    Atkinson JH; Slater MA; Wahlgren DR; Williams RA; Zisook S; Pruitt SD; Epping-Jordan JE; Patterson TL; Grant I; Abramson I; Garfin SR
    Pain; 1999 Nov; 83(2):137-45. PubMed ID: 10534584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.
    Romeo R; Patel A; Knapp M; Thomas C
    Int Clin Psychopharmacol; 2004 May; 19(3):125-34. PubMed ID: 15107654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
    Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
    Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients.
    Hoencamp E; Haffmans PM; Dijken WA; Hoogduin CA; Nolen WA; van Dyck R
    J Affect Disord; 1994 Mar; 30(3):219-27. PubMed ID: 8006248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
    Filip V; Höschl C; Karen P; Seifertová D; Bornová L; Prasková H; Prasko J
    Br J Psychiatry Suppl; 1993 Sep; (21):35-8. PubMed ID: 8217066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
    Szegedi A; Kohnen R; Dienel A; Kieser M
    BMJ; 2005 Mar; 330(7490):503. PubMed ID: 15708844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
    J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.